COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 800: Articles 7991-8000  | Next

Modeling and Global Sensitivity Analysis of Strategies to Mitigate Covid-19 Transmission on a Structured College Campus
Zhao, L., Santiago, F., Rutter, E. M., Khatri, S., Sindi, S.
10.1101/2022.04.01.22273316 — Posted: 2022-04-01
Interpretation of non-responders to SARS-CoV-2 vaccines using WHO International Standard
Zeng, Q., Yang, X., Gao, Q., Lin, B.-y., Li, Y.-z., Huang, G., Xu, Y.
10.1101/2022.03.31.22273272 — Posted: 2022-04-01
The impact of COVID-19 pandemic on influenza surveillance: a systematic review and meta-analysis
Sabeena, S., Ravishankar, N., Robin, S.
10.1101/2022.03.31.22273236 — Posted: 2022-04-01
Engagement of health workers and peer educators from the National Adolescent Health Programme-Rashtriya Kishor Swasthya Karyakram during the COVID-19 pandemic: findings from a situational analysis
Arora, M., Dringus, S., Bahl, D., Rizvi, Z., Maity, H., Lama, S., Mason-Jones, A. J., Kumar, D., Koul, P., Bassi, S.
10.1101/2022.03.28.22273059 — Posted: 2022-04-01
Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial
Ader, F., Bouscambert Duchamp, M., Hites, M., Peiffer Smadja, N., Poissy, J., Belhadi, D., Diallo, A., Delmas, C., Saillard, J., Dechanet, A., Fougerou, C., Le, M. P., Peytavin, G., Mercier, N., Velou, P., Tubiana, S., Lescure, X., Faure, E., Nseir, S., Richard, J. C., Wallet, F., Goehringer, F., Lefevre, B., Kimmoun, A., Raffi, F., Gaborit, B., Reignier, J., Lanoix, J. P., Andrejak, C., Zerbib, Y., Bani Sadr, F., Mourvilliers, B., Danion, F., Ruch, Y., Clere Jehl, R., Le Moing, V., Klouche, K., Lacombe, K., Martin Blondel, G., Vardon Bounes, F., Cabie, A., Turmel, J. M., Piroth, L., Blot, M., Botelho Nevers, E., Gagneux Brunon, A., Thiery, G., Benezit, F., Gaci, R., Mootien, J., Gallien, S., Garot, D., Bouiller, K., Epelboin, L., Jaureguiberry, S., Gaymard, A., Verschelden, G., Braz, S., Ferreira Ribeiro, J. M., Joannidis, M., Staub, T., Altdorfer, A., Greil, R., Egle, A., Guedj, J., Noret, M., Roncon Albuquerque, R., Paiva, J. A., Lina, B., Costagliola, D., Yazdanpanah, Y., Burdet, C., Mentre, F., DisCoVeRy Study Group
10.1101/2022.03.30.22273206 — Posted: 2022-03-31
Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19
Recktenwald, S. M., Simionato, G., G.M. Lopes, M., Gamboni, F., Dzieciatkowska, M., Meybohm, P., Zacharowski, K., von Knethen, A., Wagner, C., Kaestner, L., D'Alessandro, A., Quint, S.
10.1101/2022.03.31.22273226 — Posted: 2022-03-31
Size of societal volunteering predicts COVID-19 mortality
Schiltz, F., Van Remoortel, H., Scheers, H., Vandekerckhove, P.
10.1101/2022.03.31.22273238 — Posted: 2022-03-31
Changing characteristics over time of individuals receiving COVID-19 vaccines in Denmark: A population-based descriptive study of vaccine uptake
Reilev, M., Olesen, M., Kildegaard, H., Stovring, H., Andersen, J. H., Hallas, J., Lund, L. C., Ladebo, L., Ernst, M. T., Damkier, P., Jensen, P. B., Pottegard, A., Rasmussen, L.
10.1101/2022.03.25.22272927 — Posted: 2022-03-31
Predicting the time course of replacements of SARS-CoV-2 variants using relative reproduction numbers
Piantham, C., Ito, K.
10.1101/2022.03.30.22273218 — Posted: 2022-03-31
Reducing societal impacts of SARS-CoV-2 interventions through subnational implementation
Dekker, M. M., Coffeng, L. E., Pijpers, F. P., Panja, D., de Vlas, S. J.
10.1101/2022.03.31.22273222 — Posted: 2022-03-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).